As a joint venture of Brigham and Women’s Hospital and Harvard School of Public Health, Ariadne Labs was created in the fall of 2012 to focus on the discovery of ways to transform the effectiveness and appropriateness of care at the most dangerous and costly moments in people’s lives–from childbirth to care at the end of life.
Deputy Director, Science and Program Director, Safe Surgery
Program Director, End of Life
Platform Director, Informatics & Measurement
Program Director, BetterBirth
Deputy Director, Internal Operations
Chief of Staff and Deputy Director, External Relations
Donald M. Berwick is a senior fellow at American Progress. He is one of the nation’s leading authorities on health care quality and improvement. In July 2010, President Barack Obama appointed Dr. Berwick to the position of administrator of the Centers for Medicare and Medicaid Services, or CMS, a position he held until December 2011. Berwick is the former president and CEO of the Institute for Healthcare Improvement, or IHI, an organization that Dr. Berwick co-founded and led for more than 20 years. A pediatrician by background, Dr. Berwick has served as clinical professor of pediatrics and health care policy at Harvard Medical School, professor of health policy and management at the Harvard School of Public Health, and as a member of the staffs of Boston’s Children’s Hospital Medical Center, Massachusetts General Hospital, and the Brigham and Women’s Hospital. He has also served as vice chair of the U.S. Preventive Services Task Force, the first “independent member” of the Board of Trustees of the American Hospital Association, and chair of the National Advisory Council of the Agency for Healthcare Research and Quality. An elected member of the Institute of Medicine, or IOM, Dr. Berwick served two terms on the IOM’s governing council and was a member of the IOM’s Global Health Board. He also served on President Bill Clinton’s Advisory Commission on Consumer Protection and Quality in the health care Industry.
Berwick is a recipient of numerous awards, including the 1999 Joint Commission’s Ernest Amory Codman Award, the 2002 American Hospital Association’s Award of Honor, the 2006 John M. Eisenberg Patient Safety and Quality Award for Individual Achievement from the National Quality Forum and the Joint Commission on Accreditation of Healthcare Organizations, the 2007 William B. Graham Prize for Health Services Research, and the 2007 Heinz Award for Public Policy from the Heinz Family Foundation. In 2005, he was appointed “Honorary Knight Commander of the British Empire” by the Queen of England, the highest honor awarded by the United Kingdom to non-British subjects, in recognition of his work with the British National Health Service. Berwick is the author or co-author of more than 160 scientific articles and 4 books. He received his B.A. from Harvard College, his M.P.P. from the John F. Kennedy School of Government at Harvard University, and his M.D. from Harvard Medical School.
Mr. Andrew Dreyfus is President and Chief Executive Officer for Blue Cross Blue Shield of Massachusetts. Serving nearly 3 million members, BCBSMA is one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country. As CEO, Dreyfus leads the company’s effort to make quality health care affordable.
Prior to being named CEO in September 2010, Dreyfus served as BCBSMA’s Executive Vice President of Health Care Services. In that position, he led the company’s collaborative efforts to improve the quality and safety of health care in Massachusetts, including the development of BCBSMA’s Alternative Quality Contract, an innovative model which is currently one of the largest commercial payment reform initiatives in the nation.
Dreyfus previously served as the first President of the Blue Cross Blue Shield of Massachusetts Foundation, which works to expand access to health care for Massachusetts residents. During his tenure, the Foundation launched a series of policy initiatives, including the “Roadmap to Coverage,” which contributed to the successful passage of the state’s landmark 2006 Health Reform Law.
Dreyfus is Chairman of the Board of the United Way of Massachusetts Bay and Merrimack Valley, and also serves on the boards of the Schwartz Center for Compassionate Healthcare, the National Institute for Health Care Management (NIHCM), Jobs for Massachusetts, and the Boston University School of Public Health Dean’s Advisory Board and the Ariadne Labs Advisory Board.
Dreyfus previously served as Executive Vice President of the Massachusetts Hospital Association (MHA), and held a number of senior positions in Massachusetts state government, including Undersecretary of Consumer Affairs and Business Regulation.
Mr. David Ebersman is Chief Financial Officer of Facebook, where he leads the finance, facilities and information technology teams.
Prior to joining Facebook in September 2009, Ebersman worked at Genentech Inc., a leading biotechnology company, most recently as its Chief Financial Officer and Executive Vice President. Ebersman joined Genentech in 1994 and served in a number of roles, including Senior Vice President, Product Operations; Vice President, Product Development; and Director, Business Development. Prior to Genentech, Ebersman worked as a research analyst at Oppenheimer & Company Inc. He serves on the board of Ironwood Pharmaceuticals and was selected as a Fellow in the Henry Crown Fellowship Program.
Ebersman holds a bachelor’s in economics and international relations from Brown University.
Dr. Julio Frenk, M.D., M.P.H., Ph.D. serves as the dean of the Harvard School of Public Health. Dr. Frenk served as a director of EngenderHealth, Inc. He served as Mexico's minister of health from 2000 to 2006, leading a ground-breaking and internationally recognized effort to transform the national insurance and public health system. During his 25-year career, Dr. Frenk has been a senior fellow of the Bill and Melinda Gates Foundation's Global Health Program and held executive positions at the World Health Organization and the Mexican Health Foundation. Dr. Frenk holds a medical degree from the National Autonomous University of Mexico, as well as a master's degree in public health and a joint doctorate in medical care organization and sociology from the University of Michigan.
Ms. Mala Gaonkar is co-portfolio manager at investment firm Lone Pine Capital LLC, a role she has held since 1998. After graduating in economics at Harvard in 1991, she worked for The Boston Consulting Group, primarily in Munich and Hong Kong and completed her MBA at Harvard Business School before Lone Pine's inception.
She is a trustee of the Clinton Health Access Initiative (CHAI), of Ariadne Labs (a joint venture between Brigham and Women's Hospital and The Harvard School of Public Health) and of the Global Health Delivery Partnership. She is also a trustee of The Paris Review Foundation and of Tate.
Eric Lander is the founding director and serves as a core member of the Broad Institute of MIT and Harvard. One of the principal leaders of the Human Genome Project, he and his colleagues have a long-standing interest in applying genomics to understand the molecular basis of human physiology and disease.
Lander was an assistant and associate professor of managerial economics at Harvard Business School from 1981 to 1990. He has been on the MIT faculty since 1989 and the Harvard faculty since 2004. He is currently a professor of biology at MIT and professor of systems biology at Harvard Medical School. In 1990, he founded the Whitehead Institute/MIT Center for Genome Research, which was a flagship of the Human Genome Project and became part of the newly founded Broad Institute in 2003.
Lander is an elected member of the US National Academy of Sciences, the US Institute of Medicine, and the American Academy of Arts and Sciences. He is the recipient of numerous awards, including the MacArthur Foundation Fellowship, the Gairdner International Award, the Max Delbrück Medal, the AAAS Award for Public Understanding of Science and Technology, and 8 honorary doctorates. He received the Albany Medical Center Prize in Medicine and Biomedical Research, and the New York Academy of Medicine Medal for Distinguished Contributions in Biomedical Science. Lander has been a member of the board of trustees at Boston University since 2008. In 2009, President Barack Obama appointed him to co-chair the President’s Council of Advisors on Science and Technology. Lander earned his B.A. in mathematics from Princeton University and his Ph.D. in mathematics from Oxford University as a Rhodes Scholar.
Elizabeth Nabel, M.D. is the president of Brigham and Women's Health Care (BWHC), comprised of BWH and Brigham and Women’s Faulkner Hospital. Prior to her position at BWHC, Dr. Nabel served as the director of the National Heart, Lung, and Blood Institute at the National Institutes of Health. In this capacity, Dr. Nabel oversaw an extensive national research portfolio with an annual budget of approximately $3 billion to prevent, diagnose, and treat heart, lung, and blood diseases. Dr. Nabel conducted her internal medicine and cardiovascular training at BWH and Harvard Medical School, followed by senior faculty positions at the University of Michigan Medical School where she directed the Division of Cardiology and the Cardiovascular Research Center.
As a physician-scientist, Dr. Nabel has made substantial contributions to our understanding of molecular genetics of cardiovascular diseases. Among her leadership efforts as NHLBI director, Dr. Nabel launched new scientific programs in genetics and genomics, stem and progenitor cell biology, translational research, global health, and support for young investigators. Her awards include the Willem Einthoven Award; the Amgen-Scientific Achievement Award; the American Heart Association Distinguished Achievement Awards; the Eugene Braunwald Academic Mentorship Award; the Distinguished Alumni Award from Weill Cornell Medical College; the Lewis Katz Research Prize in Cardiovascular Research and 4 honorary doctorates. She is a member of the American Academy of the Arts and Sciences, the Institute of Medicine (Council) of the National Academy of Sciences, the Association of American Physicians (Council), and a fellow of the American Association for the Advancement of Science. Dr. Nabel has served on the board of reviewing editors for Science and currently is on the editorial board of the New England Journal of Medicine and Science Translational Medicine. She is a partner on 17 patents and the author of more than 250 scientific publications.
Dr. Nabel received her M.D. from Weill Cornell Medical College.
Jason Yeung, M.Phil is a Managing Director and Portfolio Manager at Morgan Stanley with a focus on Investment Management Growth Funds. He has been employed at Morgan Stanley since 2002. His career has focused on investments in the healthcare space.
Jason graduated from Johns Hopkins University with a Bachelor of Arts in International Relations and he was also a Phi Beta Kappa recipient. Jason also holds a MPhil in International Relations from the University of Cambridge. He serves as a board member of Lifebox Foundation Inc. and co-chair of the Young Partners Board of the Public Theater of New York City.
William R. Berry is deputy director and the chief science and implementation officer of Ariadne Labs: a joint center for health system innovation and the program director for the Safe Surgery 2015 initiative. Prior to this, he was the Boston project director of the Safe Surgery Saves Lives initiative with the World Health Organization’s Patient Safety Program. He attended Johns Hopkins University School of Medicine and achieved board certification in General Surgery, Thoracic Surgery and Surgical Critical Care. After 17 years in practice as a cardiac surgeon, he attended the Kennedy School of Government and the School of Public Health at Harvard. He serves as an associate medical director to the CRICO/Risk Management Foundation of the Harvard Medical Institutions. Additionally, he is the director of the surgical simulation program at the Center for Medical Simulation in Cambridge, MA, with an interest in team training for surgeons. For the last 8 years, he has also been faculty for the Institute for Healthcare Improvement in collaborative projects focused on improving the safety of surgical patients.
Susan D. Block, M.D., is the chair of the Department of Psychosocial Oncology and Palliative Care at Dana-Farber and Brigham and Women’s Hospital, Co-Director of the Harvard Medical School Center for Palliative Care, and professor of psychiatry and medicine at Harvard Medical School. She is the leader of the Serious Illness Communication Checklist Project at Ariadne Labs, a joint center for health care innovation at Brigham and Women’s Hospital and Harvard School of Public Health. Dr. Block has been a national leader in the development of the field of palliative medicine, has led major innovative educational projects in a variety of areas, is known internationally as an expert in medical education and faculty development, and has contributed to research in medical education, palliative care, psychooncology, and health system change. She is the founding chair of the Department of Psychosocial Oncology and Palliative Care, one of the largest palliative care programs in the U.S.
Leonard D’Avolio, Ph.D., is Director of the Informatics and Measurement Platform at Ariadne Labs. In this role, Dr. D’Avolio works across all project teams to design and develop infrastructure and methods to turn raw data into actionable knowledge. This includes everything from building a scalable infrastructure to support international project data capture and analysis to the development of software capable of detecting novel relationships across heterogeneous data sources.
For the past 5 years, Dr. D’Avolio was head of an informatics group he founded within the Department of Veterans Affairs, Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). There he was responsible for the development of national programs such as the development of the VA’s genomic science infrastructure and the first randomized controlled trial embedded entirely within an electronic medical record system. He also developed several software programs to make data mining and natural language processing accessible to non-technical end users. Dr. D’Avolio has also been an external advisor on several projects funded by AHRQ and NIH focused on using information technology to improve the conduct of clinical science and care.
Dr. D’Avolio earned his Master’s Degree in Information Technology from the McCallum School of Business at Bentley University and his PhD, which brought him expertise in natural language processing, from the University of California, Los Angeles. Prior to obtaining his graduate degrees he spent several years in the software industry.
Atul Gawande M.D., M.P.H. is a surgeon, writer, and public health researcher. He practices general and endocrine surgery at Brigham and Women’s Hospital in Boston. He is professor in the Department of Health Policy and Management at the Harvard School of Public Health and professor of Surgery at Harvard Medical School. He is also director of Ariadne Labs, a joint center for health system innovation at BWH and HSPH, developing scalable innovations to transform safety and performance in medicine.
In addition, he has been a staff writer for The New Yorker magazine since 1998. He has written three New York Times-bestselling books: COMPLICATIONS, which was a finalist for the National Book Award in 2002; BETTER, which was selected as one of the 10 best books of 2007 by Amazon.com; and THE CHECKLIST MANIFESTO. He is founder and chairman of Lifebox, an international not-for-profit implementing systems and technologies to reduce surgical deaths globally.
He has won 2 National Magazine Awards, AcademyHealth’s Impact Award for highest research impact on health care, a MacArthur Award, and selection by Foreign Policy magazine and TIME magazine as one of the world’s top 100 influential thinkers.
Dr. Ringer is the chief of Newborn Medicine at Brigham and Women’s Hospital (BWH) in Boston, MA, and is assistant professor of pediatrics at Harvard Medical School. BWH is a major academic medical center affiliated with Harvard Medical School and is the largest maternity hospital in Massachusetts with over 9000 births annually. The 48 bed NICU serves over 1400 infants each year, including over 120 with birth weights less than 1000 grams.
Dr. Ringer was born in Boston, MA, and received his BA from Brandeis University. He then received his M.D. and Ph.D. (Biochemistry) from Case Western Reserve University in Cleveland, OH. He completed his residency in pediatrics at Rainbow Babies and Children’s Hospital, and his fellowship in neonatal-perinatal medicine at the then joint program in Neonatology of Harvard Medical School, at Brigham and Women’s Hospital, Beth Israel Hospital, and Children’s Hospital of Boston.
He was Medical Director of the NICU at Brigham and Women’s Hospital from 1988 to 2006 and director of Newborn Services from 1988 to 2000, and has been chief of newborn medicine since 2000. He is a member of the steering committee of The Neonatal Resuscitation Program of the American Academy of Pediatrics and has actively taught resuscitation through that program for over 20 years across the United States and in many countries across the world. He is on the editorial board of NeoReviews.
He is actively involved in several areas of clinical research with the bulk of his effort spent on the development of international programs for advancing newborn care in the developing world. He has expanded his efforts over the past 5 years to include work in Ethiopia but has been actively involved in programs aimed at developing and improving care, as well as multiple teaching and training programs in numerous provinces and all major cities of Vietnam (including Da Nang) for over 12 years.
Ariadne Labs is funded through federal, foundation, and corporate grants.
If you are interested in giving to Ariadne Labs, kindly contact: